Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Analysis.

Journal Article (Journal Article)

OBJECTIVES: This study sought to determine how frequently patient-reported outcomes (PROs) are collected in registered clinical studies of atrial fibrillation (AF). BACKGROUND: Improving symptom burden and quality of life are important goals in the treatment of AF and are best measured with PROs. METHODS: Data from were studied to identify PROs in AF studies. All studies reporting AF as the disease condition were included, and PROs were identified by search terms within the outcome measures field. Generic and AF-specific PROs were identified and assessed by study type and year. reporting was compared with published reports of linked studies in PubMed. RESULTS: From 1999 to 2018, 1,709 studies including AF patients were posted; 238 studies (14%) included PROs. Collection of PROs was reported in 22% of trials (n = 83 of 386) studying procedural interventions and 11% of all Phase 3 studies (n = 18 of 168). Among the 238 studies with PROs, most described "quality of life" (n = 194 [82%]), and most (n = 198 [83%]) included only generic (not AF-specific) PROs. Only 17% of studies (n = 40) reporting PROs specified a previously published AF-specific tool, most commonly the AFEQT (Atrial Fibrillation Effect on QualiTy-of-life) form (n = 20 [8.4%]). Among the available PubMed citations of 391 studies, 74 studies (19%) described collecting a specific PRO tool (n = 29 [7.4%]) for an AF-specific PRO. CONCLUSIONS: Despite increased emphasis on the importance of PROs in AF, a minority of registered clinical trials reported collecting PROs, with very few using validated, AF-specific PROs. Improving outcomes that are most important to patients will necessitate increased emphasis on these PROs in pivotal clinical studies.

Full Text

Duke Authors

Cited Authors

  • Steinberg, BA; Dorian, P; Anstrom, KJ; Hess, R; Mark, DB; Noseworthy, PA; Spertus, JA; Piccini, JP

Published Date

  • May 2019

Published In

Volume / Issue

  • 5 / 5

Start / End Page

  • 599 - 605

PubMed ID

  • 31122382

Pubmed Central ID

  • PMC6540810

Electronic International Standard Serial Number (EISSN)

  • 2405-5018

Digital Object Identifier (DOI)

  • 10.1016/j.jacep.2019.03.008


  • eng

Conference Location

  • United States